Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 041850/0456 | |
| Pages: | 13 |
| | Recorded: | 02/16/2017 | | |
Attorney Dkt #: | 239669-374815/376610 |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 037767 FRAME: 0417. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14831199
|
Filing Dt:
|
08/20/2015
|
Publication #:
|
|
Pub Dt:
|
02/11/2016
| | | | |
Title:
|
DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLINE CHEMOTHERAPEUTIC AGENTS
|
|
|
Patent #:
|
|
Issue Dt:
|
04/04/2017
|
Application #:
|
14832103
|
Filing Dt:
|
08/21/2015
|
Publication #:
|
|
Pub Dt:
|
02/11/2016
| | | | |
Title:
|
DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLINE CHEMOTHERAPEUTIC AGENTS
|
|
Assignee
|
|
|
ONE KENDALL SQUARE |
SUITE B7201 |
CAMBRIDGE, MASSACHUSETTS 02139-1670 |
|
Correspondence name and address
|
|
FERNANDO ALBERDI, PH.D.
|
|
315 EAST EISENHOWER PARKWAY
|
|
SUITE 100
|
|
ANN ARBOR, MI 48108-3330
|
Search Results as of:
05/14/2024 11:10 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|